Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Mutations in <i>BRCA1</i> and <i>BRCA2</i>

Hormonal contraceptives were associated with increased BC risk for <i>BRCA1</i> mutation carriers, especially if used for longer durations. Decisions about their use in women with <i>BRCA1</i> mutations should carefully weigh the risks and benefits for each individual.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Oncology
Published
2024-10-02
DOI
https://doi.org/10.1200/jco.24.00176
Citations
18
Primary Topic
BRCA gene mutations in cancer
Type
article
Field-Weighted Citation Impact
9.91

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Mutations in BRCA1 and BRCA2

Philip Harraka, Meagan Brennan, Clare Hunt, Jessica Koehler et al.
18 citations
Journal of Clinical Oncology
BRCA gene mutations in cancer
9.91
article

Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Mutations in BRCA1 and BRCA2

Philip Harraka, Meagan Brennan, Clare Hunt, Jessica Koehler, Cass Hoskins, Sarah O’Sullivan, Nick Pachter, James A. Chamberlain, Michelle Cao, Liz Caldon, Heather Symecko, Lesley Andrews, Paul A. James, Christian Fridolin Singer, Rodney J. Scott, Alison Colley, Lara Lipton, Kelly Metcalfe, Bridget A. Robinson, Michael Leonard Friedlander, Jan Lubiński, Anna DeFazio, John L. Hopper, Ashley Crook, Jocelyn Lippey, James M. Flanagan, Leon Botes, Rebecca Dickson, David Gallego‐Ortega, William D. Foulkes, Jason S. Lee, Sophie Nightingale, Andrew N. Shelling, Georgina Fenton, Yoland Antill, Ian Campbell, Sian Greening, Joanne Dixon, Paul A. Cohen, Gargi Pathak, Kelly‐Anne Phillips, Georgia Chenevix‐Trench, Roger Laughlin Milne, Michael Field, Peter Savas, Rachael Williams, Joanne Shaw, Clara Gaff, Melissa A. Brown, Sunil R. Lakhani, Liz Lobb, Esther M. John, Deborah J. Marsh, Irene L. Andrulis, Nadine Tung, Amber M. Aeilts, Juliet D. French, Nicholas K. Hayward, Edwina Rickard, Jo Burke, Anannya Chakrabarti, Kathy Tucker, Peter C.C. Fong, Anita Skandarajah, Michael Bogwitz, Amy Pearn, Jodi M. Saunus, Manisha Chauhan, Raymond H. Kim, Simon Bodek, Eliza Courtney, Martin Delatycki, Mary Beth Terry, Susan M. Domchek, Christobel Saunders, Jia‐Min Pang, Alexa Kidd, Andrea Eisen, Gelareh Farshid, Shweta Srinivasa, Allison W. Kurian, Elizabeth Salisbury, Laura Forrest, Katherine L. Nathanson, Mike Gattas, Saundra S. Buys, Mary Ann Young, Ingrid Winship, Mitchell Lawrence, Milita Zaheed, Renea A. Taylor, David J. Amor, Ellen Pieper, Geoffrey J. Lindeman, Abi Ragunathan, Briony Patterson, Beth Y. Karlan, Rosemary L. Balleine, Alison Trainer, Stacey L. Edwards, Adrienne Sexton, Clare L. Scott, Julie K. Bassett, Marion Harris, Joanne Kotsopoulos, Graham J. Mann, Steven A. Narod, Shona O’Connell, Melissa C. Southey, Mark A. Jenkins, Sarah‐Jane Dawson, Margaret C. Cummings, Shuai Li, Jessica Taylor, Heather Thorne, Alice Christian, Jane Visvader, Judy Kirk, Peter Simpson, Amanda Spurdle, Michael F. Buckley, Jacek Gronwald, Logan Walker, Sue Anne McLachlan, Mary B. Daly, Bettina Meiser, Phyllis Butow, Andrew Fellows, Peter George, Stewart Hart, Deepa Chauhan, James Kollias, Susan Ramus, Mona Saleh, Ian Bennett, Stephen Fox, Sherene Loi, James Cui, Jonathan Beesley, Wanda Cui
article en
18 citations

Abstract

Hormonal contraceptives were associated with increased BC risk for <i>BRCA1</i> mutation carriers, especially if used for longer durations. Decisions about their use in women with <i>BRCA1</i> mutations should carefully weigh the risks and benefits for each individual.

Journal of Clinical OncologyVol. 43(4)
Ontario Institute for Cancer Research (CA), Fox Chase Cancer Center (US), Mount Sinai Hospital (CA), Beth Israel Deaconess Medical Center (US), Sunnybrook Health Science Centre (CA), University Health Network (CA), University of California, Los Angeles (US), The University of Melbourne (AU), University of Toronto (CA), Cancer Council Victoria (AU), Lunenfeld-Tanenbaum Research Institute (CA), University of Utah (US), Columbia University Irving Medical Center (US), Royal Hospital for Women (AU), Peter MacCallum Cancer Centre (AU), Huntsman Cancer Institute (US), Women's College Hospital (CA), Princess Margaret Cancer Centre (CA), UNSW Sydney (AU), Comprehensive Cancer Center Vienna (AT), Monash Health (AU), Public Health Ontario (CA), International Hereditary Cancer Center (PL), McGill University (CA), The Ohio State University (US), Monash University (AU), Medical University of Vienna (AT), Columbia University (US), University of Pennsylvania (US), Pomeranian Medical University (PL), Stanford University (US)
AstraZeneca, GlaxoSmithKline, Clovis Oncology, NRG Oncology, National Cancer Institute
Good health and well-being
Openalex Percentile: Top 1%
BRCA gene mutations in cancer
9.91
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.